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Abstract 
The minimum inhibitory concentrations (MICs) o f  6 different 
antibiotics (chloramphenicol, clindamycin, erythromycin, 
streptomycin, tetracycline and vancomycin) were deter- 
mined for 143 strains of  lactic acid bacteria and bifidobacte- 
ria using the Etest. Different MlCs were found for different 
species and strains. Based on  the distribution o f  these MIC 
values, most o f  the strains were either susceptible or intrinsi- 
cally resistant t o  these antibiotics. However, the MIC range 
of  some of  these antibiotics showed a bimodal distribution, 
which suggested that some o f  the tested strains possess ac- 
quired antibiotic resistance. Screening for resistance genes 
was performed by  PCR using specific primers, or using a DNA 
microarray with around 300 nucleotide probes representing 
7 classes o f  antibiotic resistance genes.The genes identified 
encoded resistance t o  tetracycline [tet(M), tet(W), tet(0) and 
tet(OIW)], erythromycin and clindamycin [erm(B)I and strep- 
tomycin [aph(E) and sat(3)l. Internal portions of  some of  
these determinants were sequenced and found t o  be  identi- 
cal t o  genes described in  other bacteria. All resistance deter- 
minants were located on  the bacterial chromosome, except 
for tet(M), which was identified o n  plasmids in  Lactococcus 
lactis. The contribution o f  intrinsic multidrug transporters t o  
the antibiotic resistance was investigated by cloning and 
measuring the expression o f  Bifidobacterium breve genes in  
L. /actis. Copyright O 2008 S. Karger A t ,  Basel 
Introduction 
The  resistance o f  bacteria t o  antibiotics is a n  increas- 
ingly impor tant  publ ic health problem worldwide. There 
i s  a pressing need t o  limit the spread o f  resistance genes, 
since these could be  transferred t o  opportunistic and 
pathogenic bacteria [Blizquez et al., 20021. Ant ibiot ic re- 
sistance can be 'intrinsic' or 'acquired' [Anadbn et al., 
20051. In t r ins ic  o r  'natural' resistance i s  inherent t o  a bac- 
ter ial  species a n d  involves the absence o f  the target o r  the 
U R G E R  O 2008 S. Karger AG, Basel Mohammed Salim Ammor 
1464-1801108/0143-0006$24.50/0 Institute de Productos Ecteos de Asturias (CSIC) 
Fax+4161306 1234 Carretera de lnfiesto sln 
E-Mail karger@karger.ch Accessible online at: ES-33300 Villaviciosa (Spain) 
wmv.karger.com www.karger.comlmmb Tel. +34 985 89 12 31, Fax +34 985 89 22 33, E-Mail ammor@ipla.csic.es 
presence of low-affinity targets, low cell permeability, an- 
tibiotic inactivation of the antibiotics and the presence of 
efflux mechanisms. The acquisition of antibiotic resis- 
tance occurs via the mutation of pre-existing genes or by 
horizontal transmission. With some exceptions, intrinsic 
resistance and resistance by mutation are unlikely to be 
disseminated; horizontally transferred genes, particular- 
ly those carried on mobile genetic elements, are those 
most likely to be transmitted [Normark and Normark, 
20021. 
The food chain has been recognized as one of the main 
routes of transmission of antibiotic resistance from ani- 
mal to human bacterial populations [Teuber et al., 1999; 
Witte, 20001. More specifically, fermented products that 
are not heat treated before consumption provide a vehicle 
for transmission from the indigenous microbiota of ani- 
mals to the bacteria of the human gastrointestinal tract 
(GIT) [Bates et al., 1994; Nikolich et al., 19941. 
Either added as a starter or present in raw materials, 
many lactic acid bacteria (LAB) species participate in the 
manufacture and preservation of fermented foods and 
feed products. LAB are also commonly found, together 
with bifidobacteria (LAB&B), among the resident micro- 
biota of the GIT of humans and animals. LAB&B have 
considerable potential as probiotics based on their long 
history of safe use and a growing body of evidence sup- 
porting their positive health-promoting effects [Ouwe- 
hand et al., 20021. However, attention is currently being 
paid to commensal LAB&B with respect to their poten- 
tial role in the spread and transmission of antibiotic re- 
sistance determinants in food matrices and into the GIT 
[Teuber et al., 19991. This interest is strengthened by the 
fact that a large number of these bacteria are extensively 
used for large-scale feed, food and probiotic industrial 
manufacture. Further, the number of papers reporting 
the isolation of antibiotic-resistant LAB&B strains is in- 
creasing [Ahn et al., 1992; Danielsen, 2002; Fons et al., 
1997; Perreten et al., 1997; Scott et al:, 2000; Tannock et 
al., 19941. Therefore, there is a need to establish clear cut- 
off values for separating susceptible and resistant bacte- 
ria, to distinguish between intrinsic and acquired forms 
of resistance, and to study the molecular mechanisms re- 
sponsible for the spread of resistance among the LAB&B 
community. 
The aim of this study was to assess the antibiotic resis- 
tance patterns of a large collection of LAB&B strains 
from dairy and intestinal sources and to characterize the 
genetic determinants responsible for the resistances. The 
role of intrinsic multidrug resistance (MDR) transporters 
in antibiotic resistance was also addressed. 
- -  - 
Antibiotic Resistance in Lactic Acid 
Bacteria and Bifidobacteria 
Results and Discussion 
Antibiotic Susceptibility Patterns of LAB&B Strains 
Tables 1 and 2 show the minimum inhibitory concen- 
tration (MIC) ranges of 6 antibiotics for 143 LAB&B 
strains isolated from different environments when clus- 
tered into 7 groups: Lactococcus lactis (SO), Lactobacillus 
plantarum (29), Lactobacillus acidophilus-Lactobacillus 
delbrueckii (1 L. acidophilus, 1 Lactobacillus amylovorus, 
7 L. delbrueckii, 3 Lactobacillusgasseri, and 2 Lactobacil- 
Ius johnsonii), other lactobacilli (3 Lactobacillus brevis, 1 
Lactobacillus casei, 1 Lactobacillus fermenturn, 1 Lacto- 
bacillus helveticus, 2 Lactobacillus paracasei, 1 Lactoba- 
cillus pentosus, 1 Lactobacillus reuteri, 3 Lactobacillus 
rhamnosus, 1 Lactobacillus sakei and 1 Lactobacillus va- 
ginalis), Bifidobacterium longum (17), Bifidobacterium 
bifidum (6) and other bifidobacteria (1 Bifidobacterium 
adolescentis, 2 Bifidobacterium animalis, 1 Bifidobacte- 
rium breve, 4 Bifidobacterium pseudocatenulatum, 2 Bifi- 
dobacterium pseudolongum and 1 Bifidobacterium ther- 
mophilus). 
The distinction between natural and acquired resis- 
tance is of great importance, since only the latter has a 
serious chance of being transferred [Anadbn et al., 20051. 
Analysis of MICs and their distributions helps differenti- 
ate between these 2 resistance mechanisms. The MIC dis- 
tribution of a given antibiotic for a single bacterial species 
in the absence of resistance mechanisms should approach 
statistical normality [Murray et al., 20031. As an example, 
figure 1 shows the MIC distributions of erythromycin 
(normal distribution) and tetracycline (bimodal distri- 
bution, thus suggesting the possession of acquired resis- 
tance) for the L. lactis strains. 
Both the LAB and bifidobacteria were susceptible to 
chloramphenicol (MIC range 0.032-12 pglml; table 1). 
These results agree with data published elsewhere [Dan- 
ielsen and Wind, 2003; Delgado et al., 2005; F16rez et al., 
2005; Zarazaga et al., 1999; Zhou et al., 20051. According 
to the clinical breakpoint of this drug (232 pglml) [Clin- 
ical and Laboratory Standards Institute, 20041, none of 
the strains could be considered resistant. However, at 
least 4 lactobacilli could be considered resistant (1 strain 
each of L. plantarum, L. johnsonii, L. rhamnosus and 
L. vaginalis) if MICs were compared to the breakpoints 
recently proposed by the FEEDAP Panel [Anadbn et al., 
20051. The unimodal distribution of the MICs, however, 
does not support the presence of acquired resistance (data 
not shown). 
The MICs of erythromycin and clindamycin for most 
of the LAB&B strains assayed (table 1) were within the 
Table 1. Distribution of MICs of chloramphenicol, clindamycin and eryt'hromycin (antibiotics that inhibit protein synthesis; target 
50s ribosomal subunit) for LAB&B species from different environments 
Anti- Species Strains Isolates with the following MICs (in pg rnl-I), n 
biotica n 
<0.032 0.064 0.125 0.25 0.5 1 2 4 8 16 32 64 128 2256 
Cm L. lactis 50 3 30 12 5 
- - - - - - - 
L. plantarum 29 6 1 6 6  1 
L. acido~hilus/L. delbrueckii 15 1 1 5  7 1  
Other lactobacilli 15 4 4 5 2  
B. bifidum 6 2 4 
Other bifidobacteria 11 3 6 2  
Ery L. lactis 50 3 10 30 4 3 
L. plantarum 29 2 11 13, 2 1 
L. acidophilus/ 15 3 2 2 6  1 1 
L. delbrueckii 
Other lactobacilli 15 3 4 2 2 2 2 
B. longurn 17 1 2 6 1 2 5 
B. bifidum 6 1 3 2 
Other bifidobacteria 11 1 1 6  2 1 
Clin L. lactis 50 4 10 14 18 4 
L. ~lantarum 29 4 2 5 3 6 7 2  
L. acidophilud 15 4 1 2 1 1  2 2 1  1 
L delbrueckii 
Other lactobacilli 15 2 1 4  2 1 2 1  1 1  
B. longum 17 3 2 1 4 7 
B. bifidum 6 2 2 2 
Other bifidobacteria 11 4 4 1 1  1 
" Cm = Chloramphenicol; Ery = erythromycin; Clin = clindamycin. 
normal range of susceptibility [Clinical and Laboratory - 
Standards Institute, 20041. Variations in the MICs of 
erythromycin and clindamycin similar to those obtained 
in the present work have been reported by other authors 
[Danielsen and Wind, 2003; Delgado et al., 20051. Moder- 
ate levels of clindamycin resistance (8-32 pglml) have 
previously been observed in L. gasseri Danielsen and 
Wind, 20031. Based on these results, the raising of the cut- 
off value for clindamycin in this species should be con- 
sidered. Nevertheless, the bimodal distribution of MICs 
strongly suggests that certain intestinal isolates possess 
acquired resistance mechanisms. Resistance to both an- 
tibiotics was usually observed in the same strain, suggest- 
ing a common resistance mechanism [the so-called mac- 
rolide-lincosamide-streptogramin (MLS) phenotype]. 
The LAB&B strains showed a wide range of strepto- 
mycin MICs (2 to >256 pglml; table 2), as reported else- 
where [Delgado et al., 2005; Katla et al., 20011. However, 
a clear streptomycin cut-off MIC for the LAB&B strains 
is still to be defined. Indeed, the highest MIC for this 
aminoglycoside was moderate compared to the high clin- 
ical breakpoint for enterococci (r 1,024 pglml) [Clinical 
and Laboratory Standards Institute, 20041. All B. b+durn 
isolates showed a streptomycin MIC of >256 pglml. Such 
resistance might be intrinsic in this species. In addition, 
several other strains showing an MIC higher than 256 
pglml (table 2) were suspected of possessing acquired re- 
sistance to this drug (2 strains of B. pseudocatenulatum, 
2 of L. rhamnosus, and 1 strain each of B. longum, Bifido- 
bacterium pseudolongurn subsp. globosum and B. ther- 
mophilus). 
Although most strains were susceptible to tetracycline 
(table 2), their MIC distributions suggested that 11 B. lon- 
gum, 5 B. bifidum, 3 L. lactis, and 1 strain each of B. ani- 
-- 
Ammor et al. 
Table 2. Distribution of MICs of streptomycin and tetracycline (antibiotics that inhibit protein synthesis; target 30s ribosomal sub- 
unit), and of the peptidoglycane synthesis inhibitor vancomycin, for LAB&B species from different environments 
Anti- Species Strains Isolates with the following MICs (in pg ml-I), n 
biotic" n 
~0.032 0.064 0.125 0.25 0.5 1 2 4 8 16 32 64 128 2256 
Tc L. lactis 50 30 14 3 2 1 
L. plantarum 29 3 9 1 0 6  1 
L. acidophilus/L. delbrueckii 15 1 4 4 4  1 1 
Other lactobacilli 15 2 3 3 2 1  4 
B. longurn 17 3 3 6 5 
B. bifidum 6 1 5 
Other bifidobacteria 11 7 1 1 1 1 
Str L. lactis 50 5 6 8 20 11 
L. plantarum 29 2 10 13 3 1 
L. acidophilus/L. delbrueckii 15 4 7 2 2  
Other lactobacilli 15 2 1 2  5 1  2 2  
B, longurn 17 4 3 3 5 1 1  
B. bifidum 6 6 
Other bifidobacteria 11 3 1  3 4  
Iran L, lactis 50 2 9 3 5 3 1  
L. plantarum 29 29 
L. acidophilus/ 15 3 6 6  
L. delbrheckii 
Other lactobacilli 15 1 1 13 
B. longum 17 1 13 3 
B. bifidum 6 6 
Other bifidobacteria 11 7 4 
TC = Tetracycline; Str = streptomycin; Van = vancomycin. 
Fig. 1. Distribution of tetracycline MICs 
for the L. lactis strains (in black), showing 
a clear bimodal distribution, and of eryth- 
romycin MICs (in grey), showing a uni- 
modal distribution. 
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Table 3. Results of screening selected LAB&B strains for antibiotic resistance genes by PCR and DNA microar- 
ray analysis 
Species Strains Relevant phenotype Genes detected by 
examined, n PCR DNA microarrays 
B. animalis 
B. bifdum 
B. bifidum 
B. longum 
B. longum 
B. longum 
B. longum 
B. lonhm 
B. longum 
B. pseudocatenulatum 
B. pseudocatenulatum 
B. pseudocatenulatum 
L. lactis subsp. lactis 
L. brevis 
L. johnsonii 
L. plantarum 
L. plantarum 
L. rhamnosus 
L. rhamnosus 
L. vaginalis 
Strr, Tetr 
Str' 
Strr, Tetr 
susceptible 
Clinr, Eryr, Sff 
Clin: E*, SW, TeF 
Stf, Tetr tet(W) 
Stf, Tetr tet(W) 
Strr, Tetr tet(W) 
susceptible 
Sff 
Clinr, EqJ, Str' 
Tetr 
susceptible 
Clinr, Ery', Tetr 
susceptible 
Tetr 
susceptible 
Clinr, Ery', Strr 
Tetr 
Clinr, Ery: Strr and Tetr stand for clindamycin, erythromycin, streptomycin and tetracycline resistance, re- 
spectively. ND = Not done. 
The tet(W) gene detected in these strains was found to be non-functional. 
malis, B. pseudolongum subsp. globosum, L. johnsonii, 
L. plantarum, and L. vaginalis possessed potentially ac- 
quired resistance. Indeed, resistance to tetracycline has 
been widely reported in LAB&B species [Danielsen and 
Wind, 2003; Delgado et al., 2005; F16rez et al., 2005; Mou- 
bareck et al., 2005; Temmerman et al., 20031. 
Heterofermentative lactobacilli were intrinsically re- 
sistant to vancomycin (table 2), as reported by other au- 
thors [Hamilton-Miller and Shah, 19981. The resistance 
of these species to vancomycin is intrinsic, due to the 
presence of D-Ala-D-lactate in their peptidoglycan in- 
stead of the normal dipeptide D-Ala-D-Ala [Klein et al., 
20001. The obligate homofermentative lactobacilli, lacto- 
cocci and bifidobacteria, however, proved to be very sus- 
ceptible. 
Multiresistance is not a common trait in LAB&B, but 
the 2 L. rhamnosus isolates shown to be resistant to 2 an- 
tibiotics (erythromycin and dindamycin) and the L. 
johnsonii isolate proved to be resistant to 3 antibiotics 
(erythromycin, clindamycin and tetracycline) are worthy 
of note. 
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Screening for Resistance Genes by PCR and 
Sequencing 
Isolates on the right side of the tetracycline MIC dis- 
tribution curves were all screened for tetracycline resis- 
tance determinants using universal primers for genes 
encoding ribosome protection proteins [Barbosa et al., 
1999; Clermont et al., 19971. A single PCR product of the 
same size with both of the primer pairs used (DI-DII and 
tetl-tet2) was obtained for 11 B. longum, 5 B. bifidum, 3 
L. lactis, 1 B. animalis and 1 L. johnsonii strains (table 3). 
More particularly, the sequences from the amplicons of 
L. lactis proved to be 100% identical to the tet(M) gene 
present in the Tn916 transposon of Enterococcus faecalis 
[Herzog-Velikonja et al., 19941. A section of the nucleo- 
tide sequence of the amplicon obtained from L. johnsonii 
showed 99% homology with tet(W) genes, while another 
region matched the sequence of tet(0) genes, suggesting 
the determinant for this strain may be mosaic (data not 
shown). A single PCR product of around 1,250 bp was 
obtained for all the 17 tetracycline-resistant bifidobacte- 
ria, which was identical to the recently reported tet(W) 
Arnmor et al. 
gene [Barbosa et al., 1999; Scott et al., 20001. On the con- 
trary, no amplification was obtained with L. plantarum 
and L. vaginalis when using specific primers for tet(K), 
tet(L), tet(M), tet(O), tet(S) and tet(W). Preliminary re- 
sults suggested the possibility of this apparent resistance 
being an effect of the size of the inoculum (data not 
shown). 
Total DNAs of the MLS-resistant isolates were ampli- 
fied with primers specific for the erm(A), erm(B), erm(C), 
erm(F) and mef(A) genes [Luna et al., 2000; Roberts et al., 
19991. Among the 11 previously detected resistant iso- 
lates, a positive amplification product of 639 bp was ob- 
tained when using the DNA of the L. johnsonii strain as 
a template plus specific primers for erm(B). The nucleo- 
tide sequence of the amplicon showed 99% homology 
with the plasmid-encoded erm(B) gene of a L. fermentum 
strain (GenBank acession No. U48430). No amplification 
was obtained with any other erythromycin- or clindamy- 
cin-resistant strains, indicating they might harbour oth- 
er MLS resistance mechanisms. 
Screening for Resistance Genes Using DNA 
Microarrays 
Selected susceptible and resistant isolates were anal- 
ysed by DNA microarray analysis to corroborate the re- 
sults obtained by PCR screening, trying to identify pre- 
viously undetected antibiotic resistance genes. The DNA 
microarray used contained nearly 300 oligonucleotide 
probes specific for the majority of antibiotic resistance 
gene classes. Table 3 shows a summary of the results ob- 
tained by this technique, and a comparison with those 
previously obtained by PCR. In general, the results of the 
2 methods correlated well. Indeed, the presence of tet(W) 
and erm(B) was confirmed by the microarray analysis. 
Further, the DNA of 3 susceptible strains used as con- 
trols (2 B. longum and 1 B. bifidum) was found to hybrid- 
ize with tet(0) (2 strains) and tet(W) (1 strain). In this 
last strain, fragments of tet(W) were also amplified by 
PCR; however, no amplification was obtained with 
primers encompassing the whole tet(W) gene, suggest- 
ing the existence of a non-functional (interrupted) 
tet(W) gene. 
Finally, the microarray analysis also detected aph(E) 
andlor sat(3) genes in 1 B. bifidum, 2 B. pseudocatenula- 
tum, and 3 streptomycin-susceptible isolates of B. longum 
and B. pseudocatenulatum. 
Genetic Location of Resistance Genes 
Among the erythromycin- and tetracycline-resistant 
isolates, only 4 strains were found to harbour plasmids 
- 
Antibiotic Resistance in Lactic Acid 
Bacteria and Bifidobacteria 
(the 3 L. lactis strains and a single B. bifidum strain). Con- 
sequently, most resistance traits were deemed to be en- 
coded on the bacterial chromosome. Internal segments of 
tet(M) (1.5 kb), tet(W) (1.2 kb) and erm(B) (639 bp) genes 
obtained by PCR were digoxigenin-labelled and hybrid- 
ized against total and plasmid DNA digested with the 
restriction enzymes EcoRI and HindIII. Southern blot as- 
says confirmed the chromosomal location of tet(W) in 
bifidobacteria, as well as the erm(B) and tet(0IW) genes 
in L. johnsonii. These assays showed a plasmid location 
for the tet(M) gene in all 3 L. lactis strains (results not 
shown). 
MDRs of Bifidobacterium and Antibiotic Resistance 
Besides dedicated antibiotic resistance genes, several 
intrinsic mechanisms have been suggested to contribute 
to antibiotic resistance in bacteria, including the thick- 
ness and compactness of the cell wall [Cui et al., 20031, 
defective cell wall autolytic systems [Kim et al., 19821 and 
MDR transporters [Price et al., 2006; Putman et al., 20011. 
Recent studies have reported that, among the different 
Bifidobacterium species, B. breve possesses resistant lev- 
els to several antibiotics that are higher than those of oth- 
er Bifidobacterium species [Moubareck et al., 20051, indi- 
cating that it could have a stronger intrinsic resistance. 
Therefore, we selected B. breve UCC2003 as a model or- 
ganism to study the involvement of different MDR-like 
proteins in antimicrobial resistance. 
Three genes encoding proteins with homology to 
MDR proteins were cloned and expressed in L. lactis 
(bbmR, bbmA and bbmB). BbmR exhibited characteris- 
tics reminiscent ofproton motive force-driven MDR pro- 
teins, and its heterologous expression in L. lactis has been 
previously shown to confer resistance to macrolides 
[Margolles et al., 20051. By contrast, recent experimental 
evidence and homology comparison suggested that 
BbmA and BbmB form a functional heterodimeric MDR 
transporter belonging to the ABC superfamily (data not 
shown). Consequently, the effect of separated or coordi- 
nated expression of bbmA and bbmB was also studied. 
The resistance levels of control and recombinant L. lactis 
cells to different antibiotic classes are summarized in ta- 
ble 4. As previously reported [Margolles et al., 20051, the 
expression of BbmR in L. lactis increased its resistance 
levels to macrolides by a factor of 3-6. MICs of aminogly- 
cosides and antibiotics in the other groups were also in- 
creased. Separated expression of BbmA or BbmB did not 
influenced MIC of the antibiotics in L. lactis as much as 
coordinated expression of these 2 polypeptides in the 
same cell, further supporting their complementarity. 
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Table 4. Resistance levels to different antibiotic groups of control derlfing the transfer of resistance in LAB&B species 
L. lactis cells and cells expressing the MDR proteins BbmR, or would be essential for the control oftheir spread via the jointly BbmA and BbmB food chain. 
L. lactis Antibiotic class 
p-lactams tetra- amino- macro- others 
cyclines glycosides lides Experimental Procedures 
Control - - - - - 
BbmR - - + 
BbmAIBbmB - - - - +LC; +* 
- = Cells without increase in MIC compared with the control; 
+ = cells with more than 3-fold increase in MIC compared with 
the control; +/- = cells in which the MIC increased between 2- and 
3-fold compared with the control. 
a Only for streptomycin. Only for vancomycin. 
'Only for ciprofloxacin. Only for polymyxin B. 
Cells containing BbmA and BbmB increased the MIC 
more than 2-fold to ciprofloxacin, and more than 10-fold 
to polymyxin B. However, in all these cases, MIC levels 
were still low compared to those obtained by acquired 
mechanisms [Clinical and Laboratory Standards Insti- 
tute, 2004; Teuber et al., 19991. 
Conclusions 
Antibiotic resistance is not a common trait of dairy 
and intestinal LAB&B species. However, several strains 
were considered to be resistant to some antibiotics, and 
were thought to harbour acquired resistance genes. More- 
over, genes identical to those described in other bacteria 
from the same environments [ te t (~) , '  tet(OIW), tet(W), 
erm(B)] were identified in dairy and intestinal LAB&B 
strains. Microarray hybridization was found to be a pow- 
erful screening technique able to screen in a single step 
for hundreds of genes of the most common antibiotic re- 
sistance families, although positive results require con- 
firmation by other methods (hybridization, sequencing). 
When present, all resistance determinants were located 
on the bacterial chromosome, except for tet(M) which 
was identified on plasmids in L, lactis. Non-functional 
resistance genes were observed in some strains, while 
some others may harbour resistance determinants not yet 
characterized. Intrinsic mechanisms, such as those in- 
volving the membrane MDR transporters studied in this 
work, might contribute to broaden the antibiotic MIC 
ranges. Determination of the molecular mechanisms un- 
Bacterial Strains, Growth Media and Culture Conditions 
A total of 143 strains, isolated from different origins and geo- 
graphical locations and thought to be representative of a majority 
of the LAB&B species, were surveyed for antimicrobial resistance. 
Most were isolated in the period of 1998-2003, but several were 
collected during the so-called pre-antibiotic era [Teuber et al., 
19991. The 31 L. lactis and 22 L. plantarum strains were isolated 
as part of the dominant populations of artisanal starter-free 
cheeses [FMrez et al., 20051. The 12 intestinal lactobacilli and 27 
bifidobacteria belonged to the dominant populations of the faeces 
and intestinal mucosa of healthy individuals [Delgado et al., 
20051. Nineteen L. lactis, 18 lactobacilli and 7 bifidobacteria were 
provided by the Belgian Co-ordinated Collections of Microor- 
ganisms (BCCM), University of Ghent, Ghent, Belgium. Finally, 
7 L. plantarum strains were obtained from the Colecci6n Espa- 
Aola de Cultivos Tipo (CECT), University of Valencia, Valencia, 
Spain. 
Culture media were all purchased from Oxoid (Basingstoke, 
UK). Cryopreserved cultures in glycerol were first recovered on 
Mueller-Hinton agar (for L. lactis), MRS agar (for dairy lactoba- 
cilli and lactobacilli of vegetable origin) or MRS agar supplement- 
edwith 0.3 g/l cysteine-HC1 (for intestinal lactobacilli and bifido- 
bacteria; Merck, Darmstadt, Germany). Isolated colonies were 
then streaked onto Mueller-Hinton plates (for L. lactis) or onto 
lactic acid bacteria susceptibility test medium (LSM; 90% Iso- 
Sensitest and 10% MRS [Klare et al., 20051 for lactobacilli), and 
incubated for 24 h at 30°C. Colonies of intestinal lactobacilli and 
bifidobacteria were streaked onto LSM supplemented with 0.3 gll 
cysteine, and incubatedat37OC inananaerobic chamber (MacSOO; 
Down Whitley Scientific, Shipley, UK; atmosphere 10% Hz, 10% 
C02, 80% N 3  for 48 h. 
L. lactis NZ9000 was used for the heterologous cloning and 
expression of MDR genes from B. breve UCC2003. For this pur- 
pose, appropriate nisin-inducible expression vectors of the 
pNZ8000 series and previously reported conditions were utilized 
[de Ruyter et al., 19981. Control and recombinant L. lactis cells 
weregrown at 30°C in M17 broth (Oxoid) with 0.7% (wlv) glucose 
(GM17). Antibiotics (chloramphenicol, erythromycin or both) at 
5 ~ g l m l  were added to the media when necessary. 
MICs Determined by the Etest 
Individual colonies from the agar plates were suspended in 
2-5 ml of sterile saline (Oxoid) until a density corresponding to 
McFarland standard 1 or its spectrophotometric equivalent 
(-3 x lo8 CFU/ml) was obtained. 
Bacterial suspensions were plated onto the surface of Mueller- 
Hinton (or LSM) agar with a sterile cotton swab, and the plates 
were allowed to dry for approximately 15 min before applying the 
Etest strips (AB Biodisk, Solna, Sweden). MICs were recorded fol- 
lowing the manufacturer's recommendations after 48 h of incuba- 
tion at 30 or 37°C. The susceptibilities of the LAB&B strains were 
established using the clinical MIC breakpoints defined by the 
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)ecies Table 5. List o f  the antibiotic resistance genes represented b y  oligonucleotides on the microarray used i n  this study 
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211s 
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l at 
Aminoglycosides aac(3')-Ib; aac(3')-IIIb; aac(3')-IIIG aac(3')-IV; aac(6')-aph(2'); aac(6)-Il; aac(6')-Ib; aac(6')-Ic; aac(6')-Iy; 
aac(6')-Il; aac(6")-Iq; aacA1; aacAl; aacA7; aacC1; aacC2; aacC3; aacC7; aacC8; aacC9; aadA1; aadA2; aadA3; 
aadA6; aadA8; aadB; aadD; aadE; aph (2")-Ib; aph(2")-Ic; aph(2' ')-Id; aph(3')-IIa; aphA 1; aphA-lab; aphA2; 
aphA3; aphA6; aphA7; aph(E); KnR; nptII; satl; sat2; sat3 sat4; strA; strB 
Extended bla~cc-01-03; blaaa-01; ~ ~ U ~ A R B - O ~ - O S ;  bracMY-01-12; blam-M-01-38; bhDHA-01-02; blaFox-01-06; 
spectrum blal~p-01-11: blame-01-03; blaLAT-01-04; blaMIR-01-02; braMoR-01; b~aMox-01-02; blaoxA-01-35; 40; 
p-lactamaSeS1 b1ap~~-01-02; blaps~-01-02; 04-05; blaRoB-01; blasHv-01-30; bkaTEM-01-90; blaUOE-01; b1avlM-01-07 
Chloramphenicol cat; catI; catII; catIIH; catIII; catA1; catA3; catB; catB1; catB2; catB3; catB4; catBS; catB6; catB7; catB8; catB9; catD; 
catP; catQ; cmlA; cmlA1; crniA.2; mM4; crnlAS; m l A 6 ;  cmlA7; mlA-like; cm1B;JoR 
Macrolides, ere(A); ere(A2); ere(B); erm; e m ( 2 ) ;  erm(33); erm(A); e m ( A M ) ;  erm(AMR); e m ( B ) ;  erm(BC); erm(BP); erm(BZ); 
lincosamides erm(C); m ( D ) ;  erm(F); erm(G;) erm(GM); erm(GT); em(1P); erm(1M); e m ( ] ) ;  erm(K); erm(M); erm(Q); 
and strepto- erm(T); m ( T R ) ;  meflA); rneflE); mph(A); mph(B); msr(A); msr(B); sat(G); vat; vat(B); vat(C); vat(D); vat(E); 
gramins vga(A); vgb vgb(B) 
Sulfonamides sull; sul2; SUB; sulA 
Tetracyclines otr(A); otr(B) tet(30); fet(31); tet(32); tet(33); tet(34); tet(35); tet(36); tet(37); tet(A); tet(B); tet(C); tet(D); tet(E); 
tet(G); tet(H); tet(J); tet(K); tet(L); tet(M); tet(0);  tet(O/W); tet(A(P)); tet(B(P)); tet(Q); tet(S); tet(T); tet(U); 
tet(V); tet(W); tet(X); fet(Y); tet(Z) 
Trimethoprim dfrA; dfiA1; d m ;  dfiA3; dfiA5; dfrA6; dfrA7; dfrA8; dfrA9; dfiAlO; dfA12; dfiA13 dfrA14; dfiA15; dfiA16 
dfiA17; dfiA1 W dfrA20; dfiA21; dFrB; dfiB2; dfB3; dfrC; d f D ;  folA 
Vancomycin vanA; vanB; vanC1; vanCZ/C3; vanl), vanE 
' For example: blaAcc-01-03 means that oligonucleotides representing blaAcc-01, bhAcc-02 and &laAcc-03 are present on the mi- 
croarray. The  nomenclature for genes encoding for extended spectrum @-lactamases has been standardized by  adding a number to 
the gene name [for review, see Paterson and Bonomo, 20051. 
Clinical and Laboratory Standards Institute [2004], and com- 
pared to the microbiological breakpoints proposed by the FEED- 
AP Panel [Anadbn et a]., 20051. 
DNA Techniques 
Genomic DNA was isolated using a commercial kit (GenElute 
bacterial genomic DNA kit; Sigma-Aldrich Co., St. Louis, Mo., 
USA). Plasmid DNA extraction was performed as previously 
described [O'Sullivan and Klaenhammer, 19931. EcoRI- and 
HindIII-digested DNA was transferred to nylon membranes and 
hybridized with probes obtained by  PCR using oligonucleotide 
primers internal to specific genes. Hybridization and detection 
were all performed using the digoxigenin DNA-labelling and de- 
tection kit (Roche Molecular Biochemicals, Lewes, U K )  as recom- 
mended by the manufacturer. 
The presence o f  tetracycline resistance genes encoding ribo- 
somal protection proteins was checked by  PCR with 2 pairs o f  
degenerate primers: DI-DII [Clermont et a]., 19971 and tetl-tet2 
[Barbosa eta]., 19991. Additional PCR assays were performed with 
primers tetWF and tet2, specific for tet(W) [Scott et al., 20001, and 
primers DI and TetMR, specific for tet(M) [Clermont et al., 19971. 
The set o f  primers included specific oligomers for tet(K), tet(L), 
tet(M), tet(O), fet(S) and tet(W) [Gevers et al., 2003; Scott et al., 
2000l.The presence o f  macrolide, lincosamine and streptogramin 
Antibiotic Resistance in Lactic Acid 
Bacteria and Bifidobacteria 
resistance genes was checked with primers specific for erm(A), 
erm(B), errn(C), errn(F) and mef(A) genes [Luna et al., 2000; Rob- 
erts et al., 19991. Purified amplicons were sequenced by cycle ex- 
tension in an ABI 370 DNA sequencer (Applied Biosystems, Fos- 
ter City, Calif., USA). 
The  microarray assay was performed with an array containing 
300 oligonucleotides (50-60 bp long) specific for 250 antibiotic 
resistance genes o f  the following classes: aminoglycosides, ex- 
tended-spectrum @-lactamases, chloramphenicol, MLS, sulfon- 
amides, tetracyclines, trimethoprim and vancomycin (table 5). 
The spotting o f  the oligonucleotides, hybridization conditions 
and the analysis of the microarrays were as previously described 
[van Hoek et a]., 20051. 
Cloning of MDR Genes from B. breve and Expression in 
L. lactis 
To study the role of MDRs in  antibiotic resistance, a first draft 
o f  the B. breve UCC2003 genome sequence was searched for ho- 
mologous genes to  reported MDRs. Based on this homology, 3 
genes (bbmB, bbmR and bbmA) were selected, amplified by PCR, 
and cloned in  pNZ8000 vectors. In this way, constructs pN38, 
pNAbcA and pNAbcB, expressing BbmR, BbmA and BbmB, re- 
spectively, were obtained. 
J Mol Microbiol Biotechnol2008;14:6-15 13 
MIC of a large series of antibiotics in control and recombinant 
cells was assayed by Etest. The antibiotic classes analysed includ- 
ed f3-lactams (ampicillin, benzylpenicillin, ceftazidime, cephalo- 
thin and meropenem), tetracyclines (tetracycline, doxycycline 
and minocycline), aminoglycosides (kanamycin, gentamicin and 
streptomycin),macrolides(erythromycin,azithromycin,dirithro- 
mycin and clarithromycin) and others (clindamycin, polymyxin 
B, quinupristin-dalfopristin, rifampicin, trimethoprim-sulfa- 
methoxazole, vancomycin and ciprofloxacin). 
Computer Analyses 
DNA and protein sequences were analysed using the Clone 
Manager 5 computer program (Scientific and Educational Soft- 
ware, Durham, N.C., USA). Homology searches were carried out 
using the BLAST server of the NCBI (http://www.ncbi.nlm.nih. 
govl) and the software available on the PBle Bioinformatique 
Lyonnais web page (http:Npbil.univ-lyonl.fr/). 
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